Novartis AG R&D Day Transcript
Welcome, everybody, and thank you for joining us today. Thank you also for all of the people who spent the entire night going through our 180-odd slide deck. And I know you've gone through every single one, so we're anticipating a lot of questions from you all.
But anyway, no, besides that, I think it's a very busy time for you all. It's been a very busy year. Really appreciate the fact that you've taken the time to actually come here. And also a big welcome to the people who are on the webcast who are actually listening in as well.
In terms of our agenda, you've got it in the booklet at the front. So everybody can see the agenda. And for those of you on the webcast, you can see it in the Slide 3, for the agenda.
A few housekeeping points for the people actually here. The first is although the timetable actually just lists the opening, when we talk about NIBR, Pharma, Oncology, early assets, et cetera, that timetable actually includes the Q&A sessions. And what we've tried to do is to make sure that at least 40% to 50% of each
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
